The Traderszone Network

19 September, 2017 by The TZ Newswire Staff Comments Off on How Have Alts Medalists Performed?

How Have Alts Medalists Performed?

Read full story for details.
read more

19 September, 2017 by The TZ Newswire Staff Comments Off on How Have Alts Medalists Performed?

How Have Alts Medalists Performed?

Read full story for details.
read more

19 September, 2017 by The TZ Newswire Staff Comments Off on 3 Stocks to Buy with Dividend Yields Above 3%

3 Stocks to Buy with Dividend Yields Above 3%

Sometimes, chasing high dividend yields leads to higher risks than many investors are willing to take. But for income-seeking investors, particularly retirees, relatively high yields are a must. One approach is to look for solid stocks that pay attractive yields of 3% or more instead of riskier stocks with much higher yields.

Chevron (NYSE: CVX), Cisco Systems (NASDAQ: CSCO), and Pfizer (NYSE: PFE) appear to be smart picks that fit those criteria for income investors right now. Here’s why.

read more

19 September, 2017 by The TZ Newswire Staff Comments Off on 3 Stocks to Buy with Dividend Yields Above 3%

3 Stocks to Buy with Dividend Yields Above 3%

Sometimes, chasing high dividend yields leads to higher risks than many investors are willing to take. But for income-seeking investors, particularly retirees, relatively high yields are a must. One approach is to look for solid stocks that pay attractive yields of 3% or more instead of riskier stocks with much higher yields.

Chevron (NYSE: CVX), Cisco Systems (NASDAQ: CSCO), and Pfizer (NYSE: PFE) appear to be smart picks that fit those criteria for income investors right now. Here’s why.

read more

19 September, 2017 by The TZ Newswire Staff Comments Off on These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?

These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?

These are the best times in a long time for three small biotechs. For two of them, these are the best times ever.

Abeona Therapeutics (NASDAQ: ABEO), BeiGene (NASDAQ: BGNE), and Vanda Pharmaceuticals (NASDAQ: VNDA) stocks recently hit 52-week highs. Abeona and BeiGene set all-time record levels. What’s behind their recent success? More important, are these booming biotechs smart picks for investors right now?

Image source: Getty Images.

read more

19 September, 2017 by The TZ Newswire Staff Comments Off on These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?

These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?

These are the best times in a long time for three small biotechs. For two of them, these are the best times ever.

Abeona Therapeutics (NASDAQ: ABEO), BeiGene (NASDAQ: BGNE), and Vanda Pharmaceuticals (NASDAQ: VNDA) stocks recently hit 52-week highs. Abeona and BeiGene set all-time record levels. What’s behind their recent success? More important, are these booming biotechs smart picks for investors right now?

Image source: Getty Images.

read more

19 September, 2017 by The TZ Newswire Staff Comments Off on ECB policy makers disagree on setting a firm bond buying end-date in October

ECB policy makers disagree on setting a firm bond buying end-date in October

Reuters “sources” being cited 19 Sept
– some elements of decision could be put off to December
– concern over euro strength is leading to uncertainty and divide within ECB council
Funny coincidence that the last time these “sources” were trawled out the euro had also been enjoying a good time of it.